Simulation studies were conducted to estimate the statistical power of repeated low-dose challenge experiments in non-human primates to detect a candidate HIV vaccine’s effect. The effect of various design parameters on power was explored. Simulation results indicate repeated low-dose challenge studies with total sample size 50 (25 per arm) typically provide adequate power to detect a 50% reduction in the per-exposure probability of infection due to vaccination. Power generally increases with the maximum number of allowable challenges per animal, the per-exposure risk of infection in controls, and the proportion susceptible to infection
AbstractHistorically, HIV vaccines specifically designed to raise cellular immunity resulted in prot...
HIV vaccines possessing only modest, or even poor, ability to reduce susceptibility to infection cou...
This article introduces methods for use in vaccine clinical trials to help determine whether the imm...
Simulation studies were conducted to estimate the statistical power of repeated low-dose challenge e...
Simulation studies were conducted to estimate the statistical power of repeated low-dose challenge e...
Evaluation of HIV vaccine candidates in non-human primates (NHPs) is a critical step toward developi...
A critical step toward developing a successful vaccine to control the human immunodeficiency virus (...
Trials in macaque models play an essential role in the evaluation of biomedical interventions that a...
A critical step toward developing a successful vaccine to control the human immunodeficiency virus (...
<div><p>To assess the efficacy of HIV vaccine candidates or preventive treatment, many research grou...
A critical step toward developing a successful vaccine to control the human immunodeficiency virus p...
Many HIV vaccine trials have been proposed to evaluate susceptibility of individuals. However, vac c...
Repeated low-dose (RLD) challenge designs are important in HIV vaccine research. Current methods for...
Historically, HIV vaccines specifically designed to raise cellular immunity resulted in protection f...
Macaque studies of antiretroviral-containing microbicide gels administered rectally or vaginally fol...
AbstractHistorically, HIV vaccines specifically designed to raise cellular immunity resulted in prot...
HIV vaccines possessing only modest, or even poor, ability to reduce susceptibility to infection cou...
This article introduces methods for use in vaccine clinical trials to help determine whether the imm...
Simulation studies were conducted to estimate the statistical power of repeated low-dose challenge e...
Simulation studies were conducted to estimate the statistical power of repeated low-dose challenge e...
Evaluation of HIV vaccine candidates in non-human primates (NHPs) is a critical step toward developi...
A critical step toward developing a successful vaccine to control the human immunodeficiency virus (...
Trials in macaque models play an essential role in the evaluation of biomedical interventions that a...
A critical step toward developing a successful vaccine to control the human immunodeficiency virus (...
<div><p>To assess the efficacy of HIV vaccine candidates or preventive treatment, many research grou...
A critical step toward developing a successful vaccine to control the human immunodeficiency virus p...
Many HIV vaccine trials have been proposed to evaluate susceptibility of individuals. However, vac c...
Repeated low-dose (RLD) challenge designs are important in HIV vaccine research. Current methods for...
Historically, HIV vaccines specifically designed to raise cellular immunity resulted in protection f...
Macaque studies of antiretroviral-containing microbicide gels administered rectally or vaginally fol...
AbstractHistorically, HIV vaccines specifically designed to raise cellular immunity resulted in prot...
HIV vaccines possessing only modest, or even poor, ability to reduce susceptibility to infection cou...
This article introduces methods for use in vaccine clinical trials to help determine whether the imm...